{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-005980","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2024-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.795696+00:00","generated_at":"2026-05-31T07:48:53.741191+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Sonoma Pharmaceuticals files prospectus supplement for existing at-the-market equity offering","bullets":["Company entered into Equity Distribution Agreement with Maxim Group LLC on Dec 15, 2023, amended March 8, 2024.","Prospectus supplement filed Aug 23, 2024 for sales of common stock under effective S-3 registration statement.","Shares may be offered and sold through Maxim as sales agent or principal, at-the-market.","Legal opinion of Polsinelli PC regarding share validity filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-005980","json":"https://secwatch.observer/filing/0001683168-24-005980.json","markdown":"https://secwatch.observer/filing/0001683168-24-005980.md","text":"https://secwatch.observer/filing/0001683168-24-005980.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824005980/0001683168-24-005980-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824005980/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:48:53.741191+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}